Jonathan S. Batchelor


Flaxseed Ineffective in Controlling Hot Flashes

August 25th 2011

Flaxseed had no effect on reducing hot flashes in postmenopausal women who reported experiencing 28 or more hot flashes per week.

Metformin May Decrease Diabetics' Breast Cancer Risk

August 22nd 2011

In postmenopausal diabetic women, metformin use was associated with lower ER and PR breast cancer incidence.

Yoga Benefits Patients With Breast Cancer

August 19th 2011

Patients with breast cancer who undertook yoga following radiotherapy derived physical and emotional benefi ts from the ancient Indian practice, according to research presented at ASCO.

Breast Cancer Survivors Vulnerable to Long-Term Work Loss

August 17th 2011

Breast cancer survivors who stop working during chemotherapy may face the loss of long-term employment for several years after their diagnosis.

Survivorship Care Plans Do Not Improve Outcomes for Patients With Breast Cancer

August 16th 2011

A randomized trial comparing survivorship care plans with standard oncologist discharge visits in patients with breast cancer found no differences in outcomes among the groups.

Novel Therapeutics Target Gene Mutations, Tumor Suppressors

August 2nd 2011

Previously unknown genetic methylation patterns and new mutations for squamous cell carcinoma of the head and neck discovered.

Jury Still Out on Oxaliplatin for Early-Stage Colon, Rectal Cancers

July 26th 2011

Adding oxaliplatin to 5-fluorouracil before and after surgery for the treatment of locally advanced rectal cancer is demonstrating significant benefit.

Post-Oophorectomy Hormone Replacement Therapy Safe for BRCA1/2 Mutation Carriers

June 7th 2011

Women who present with BRCA1 and BRCA2 mutation face an increased risk of breast and ovarian cancer.

PTEN Expression Does Not Diminish Trastuzumab Effectiveness

June 7th 2011

Phosphatase and tensin homolog (PTEN)-positive breast cancer can be treated with trastuzumab (Herceptin) as effectively as PTEN-negative breast cancer

Three-Year Imatinib Regimen Delivers Optimal GIST Treatment

June 6th 2011

3 years of treatment with imatinib (Gleevec) after surgery in patients with high-risk GIST improved overall and recurrence-free survival

Pemetrexed Maintenance Improves Progression-Free Survival in Patients With NSCLC

June 6th 2011

Continuation maintenance with pemetrexed (Alimta) improves progression-free survival in patients with advanced nonsquamous non–small cell lung cancer

MEK and BRAF Therapy Combo Promising for Advanced Melanoma

June 5th 2011

The combination of the MEK inhibitor GSK212 and the oral BRAF inhibitor GSK436 resulted in anti-tumor activity in patients with advanced melanoma

Genetic Testing Delivers Personalized Lung Cancer Therapy

June 5th 2011

Taking a page from breast cancer treatment, clinicians managing lung cancer patients can now detect mutations that drive the development of lung cancer

NKTR-102 Shows Promise in Phase II Trial

June 5th 2011

Metastatic breast cancer patients with demonstrated disease progression after taxane therapy face an uphill battle in fighting their disease.